Keyphrases
Septic Shock
80%
Endotheliopathy
74%
Severe Sepsis
70%
Prostacyclin
70%
Intensive Care Unit
62%
Mechanically Ventilated Patients
54%
Placebo
52%
Iloprost
52%
Thrombomodulin
42%
Critically Ill Patients
41%
Randomized Controlled Trial
39%
Patients with COVID-19
38%
Procalcitonin
37%
Endothelial Damage
35%
Kidney Failure
35%
Randomized Trial
35%
Randomized Placebo-controlled Trial
35%
Sepsis
31%
Hydroxyethyl Starch
30%
Ringer's Acetate
29%
Organ Failure
28%
Bleeding
25%
Mechanical Ventilation
25%
Starch
22%
Scandinavian
22%
Investigator-initiated
22%
Prospective Cohort Study
21%
Intensive Care Patients
21%
Organ Dysfunction
21%
Allergic Reaction
20%
Low Incidence
20%
Randomized Clinical Trial
20%
Risk of Death
19%
Patient Data
19%
Hazard Ratio
18%
Placebo Groups
18%
Thyroid Volume
17%
Endothelial Activation
17%
Investigator-initiated Trials
17%
Radioiodine Therapy
17%
Arginine Methylation
17%
Guideline-directed Medical Therapy
17%
Guided Intervention
17%
Intubated Patients
17%
Balanced Crystalloids
17%
SARS-CoV-2 Infection
17%
Hypothyroidism
17%
Protocol Design
17%
Hydroxyethyl Starch 130/0.4
17%
Selective Inactivation
17%
Pharmacology, Toxicology and Pharmaceutical Science
Sepsis
91%
Placebo
89%
Prostacyclin
70%
Septic Shock
60%
Iloprost
52%
Antibiotic Agent
42%
Thrombomodulin
41%
Infection
41%
Randomized Controlled Trial
39%
Randomized Clinical Trial
37%
Procalcitonin
37%
Hetastarch
28%
Bleeding
27%
Antiinfective Agent
26%
Ringer Acetate
24%
Organ Dysfunction Score
23%
Antibiotics
23%
Adverse Event
22%
Biological Marker
22%
Prospective Cohort Study
21%
SARS Coronavirus
21%
Hypothyroidism
17%
N(g),n(g) Dimethylarginine
17%
Allergic Reaction
17%
Radioactive Iodine
17%
6 N,n' Dimethylarginine
17%
Kidney Failure
17%
Meropenem
17%
Cefuroxime
17%
Adenohypophysis Hormone
17%
Ciprofloxacin
17%
Iodine-131
17%
Anaphylaxis
17%
Graves Disease
17%
Candidiasis
17%
Piperacillin Plus Tazobactam
17%
Histamine
17%
Histamine H3 Receptor
17%
Acute Respiratory Failure
17%
Lung Infection
17%
Symptom
15%
Fibrinogen
14%
Syndecan 1
12%
Antibiotic Therapy
10%
Multiple Organ Failure
10%
Hypocoagulability
10%
Bilirubin
9%
Triacylglycerol
8%
Antimicrobial Therapy
8%
All Cause Mortality
8%
Medicine and Dentistry
Sepsis
100%
Intensive Care Unit
62%
Septic Shock
60%
Hydroxyethyl Starch
45%
Iloprost
35%
Placebo
35%
Renal Failure
35%
Bleeding
32%
Ringer Acetate
29%
Procalcitonin
29%
Intensive Care
29%
Antibiotics
29%
Shock (Circulatory)
26%
Prospective Cohort Study
21%
Infusion
21%
Thrombomodulin
21%
Infection
21%
Allergic Response
20%
Biological Marker
19%
Randomized Controlled Trial
18%
COVID-19
17%
Radioiodine Therapy
17%
Anaphylaxis
17%
Prostacyclin
17%
N(g),n(g) Dimethylarginine
17%
Hypothyroidism
17%
Iodine 131
17%
Thyroid Gland
17%
Graves' Disease
17%
Broad-Spectrum Antibiotic
17%
Arm
17%
Thromboelastography
17%
Erythrocyte Transfusion
17%
Randomized Clinical Trial
17%
Symptom
15%
Fluid Resuscitation
14%
Fibrinogen
14%
SOFA Score
12%
Multiple Organ Dysfunction Syndrome
10%
Continuous Infusion
10%
Hypocoagulability
10%
Hazard Ratio
9%
Organ Dysfunction Score
8%
Antiinfective Agent
8%
Antimicrobial Therapy
8%
SAPS II
8%
Proportional Hazards Model
8%
Adverse Event
7%
Sodium Chloride
7%
Artificial Respiration
7%
